Samjin Pharmaceuticals Market Cap

Samjin Pharmaceuticals has a market cap or net worth of 227.72 billion as of January 6, 2026. Its market cap has increased by 1.46% in one year.

Market Cap

227.72B

Enterprise Value

n/a

Revenue

274.03B

Ranking

n/a

PE Ratio

11.29

Stock Price

19,330.00

Market Cap Chart

Since August 30, 1995, Samjin Pharmaceuticals's market cap has increased from 29.12B to 227.72B, an increase of 682.00%. That is a compound annual growth rate of 7.01%.

Market Cap History

Date	Market Cap	% Change
Jan 5, 2026	226.78B	-1.67%
Dec 30, 2025	230.64B	4.07%
Dec 30, 2024	221.61B	-19.69%
Dec 28, 2023	275.94B	-19.80%
Dec 29, 2022	344.07B	5.06%
Dec 30, 2021	327.51B	-3.49%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	79.30T
Celltrion	45.84T
ALTEOGEN	25.06T
ABL Bio	11.69T
SK Biopharmaceuticals	9.87T
Yuhan	8.55T
HLB Co., Ltd.	7.09T
LigaChem Biosciences	6.41T

Market Cap Rankings